As a founding partner of Gavi, the Vaccine Alliance, the Gates Foundation has brought international attention to the cause of immunisation and has made several commitments to Gavi, totalling USD 4.1 billion to-date. In 2000, the foundation made an initial USD 750 million commitment to the Vaccine Fund, which was catalytic in bringing other donors to support vaccine delivery and creating Gavi, the Vaccine Alliance.
In February 2007, the foundation committed USD 50 million to launch the first AMC to expedite the development and availability of pneumococcal vaccines.
In June 2011, the Gates Foundation committed an additional USD 1 billion to Gavi over the period 2011-2015; of this commitment, USD 50 million was reserved for the Gavi Matching Fund.
An additional, USD 250 million of challenge grant moneys were pledged to match additional funds raised earlier by other donors.
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2018 and Q1-Q3 2019, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2019, IFFIm donor grant payments are reduced by 1.5%, however such reductions are not reflected in future contributions figures.
In June 2014 the Gates Foundation committed an additional USD 241 million to Gavi towards its complementary role on polio eradication including support for IPV over the period 2015-2018. This is complementing GPEI’s work on strengthening routine immunisation and introducing inactivated polio vaccine (IPV) in Gavi-supported countries.
At the Berlin Pledging Conference 2015, the Bill & Melinda Gates Foundation announced USD 1.55 billion for Gavi’s next 2016-202 strategic period.
Contributions and pledges in total: